Arohan Annual Report FY 20-21

5. Mr. Sumantra Banerjee Independent Director 13 11 Yes 1 3 2 Nil Nil 6. Mr. Rajat Mohan Nag Independent Director 13 11 Yes 0 3 2 Nil Nil 7. Ms. Matangi Gowrishankar Independent Director 13 12 No 4 9 3 1. Cyient Limited 2. Gabriel India Limited 3. Greenlam Industries Limited Director 8. Mr. Piyush Goenka Nominee Director 13 11 Yes 2 6 Nil 1. Shilpa Medicare Limited 2. Safari Industries (India) Limited Director 9. Mr. Kasper Svarrer Nominee Director 13 2 No Nil Nil Nil Nil Nil 10. Mr. Wilhelmus Martinus Maria Van Der Beek Nomine Director 13 9 Yes Nil 2 Nil Nil Nil 11. Mr. Paul Gratien Robine Nominee Director 13 5 Yes Nil Nil Nil Nil Nil 12. Shri Ram Meena Nominee Director 13 9 No 5 7 Nil Nil Nil 1. None of the Directors held directorships in more than ten (10) public limited companies; 2. None of the Directors is related to any Director or is a member of an extended family; 3. None of the employees of the Company is related to any of the Directors in terms the Companies Act, 2013; 4. None of the Directors has received any loans or advances from the Company during the year. 5. Mr. Sumantra Banerjee, Non-Executive Independent Director, holds 10,000 equity shares. BOARD MEMBER EVALUATION One of the key functions of the Board is to monitor and review the Board evaluation framework. The Board works with the Nomination and Remuneration Committee to lay down the evaluation criteria for the performance of the Board, including the Executives, Non-executives, Independent Directors and Nominee Directors through a peer evaluation, excluding the director being evaluated. Some of the performance indicators based on which the directors were evaluated include: • Participation in the meeting • Value addition • Time devoted to analyse and examine governance and compliance issues • Compliance with Law and relevant standards • Effectiveness of Governance • Risk Evaluation • Independence of management from Board Annual Report | 2020-2021 104